Ridge Bio
Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.
About
Ridge Bio is a biotechnology company focused on developing transformative gene therapies for patients with rare genetic diseases. Their platform aims to deliver precise and effective treatments by leveraging advanced gene editing and delivery technologies. The company is dedicated to addressing unmet medical needs and improving the lives of individuals affected by debilitating genetic conditions. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Ridge Bio do?
Ridge Bio is a Biotech company that offers Services. Teams look it up for MedTech, HealthTech, Gene Therapy. It is based in San Francisco, United States and was founded in 2021. Public records show $135M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Ridge Bio raised?
Ridge Bio has raised a total of $135M in funding. The most recent round on record is Seed.
Where is Ridge Bio headquartered?
Ridge Bio is headquartered in San Francisco, United States.
When was Ridge Bio founded?
Ridge Bio was founded in 2021.
What industry does Ridge Bio operate in?
Ridge Bio operates in Biotech, MedTech, HealthTech, Gene Therapy, Drug Discovery.
What is Ridge Bio's current status?
Ridge Bio's current operating status is: Inactive.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.